WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced it has signed a multi-year enterprise agreement with global CRO ICON. Earlier this year, the two companies announced that ICON had joined Phase Forward’s CRO Advantage Program. Since that time the partners have won a notable number of deals and ICON has increased the number of professionals who have received in-depth training in the use of Phase Forward’s InForm™ integrated trial management (ITM) electronic data capture (EDC) product.
